These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 2243441)
61. S-phase fraction after gating on epithelial cells predicts recurrence in node-negative breast cancer. Wingren S; Stål O; Sullivan S; Brisfors A; Nordenskjöld B Int J Cancer; 1994 Oct; 59(1):7-10. PubMed ID: 7523314 [TBL] [Abstract][Full Text] [Related]
62. DNA analysis in advanced breast cancer. Leivonen M; Krogerus L; Nordling S Cancer Detect Prev; 1994; 18(2):87-96. PubMed ID: 8025900 [TBL] [Abstract][Full Text] [Related]
63. [S-phase fraction and malignant potential in DNA diploid colorectal cancer]. Ando Y; Tsuchiya A; Watanabe F; Sato H; Kikuchi Y; Yoshida T; Kimijima I; Abe R Gan To Kagaku Ryoho; 1993 Apr; 20(6):771-4. PubMed ID: 8489284 [TBL] [Abstract][Full Text] [Related]
64. S-phase fraction is a prognostic factor in stage I breast carcinoma. Stål O; Dufmats M; Hatschek T; Carstensen J; Klintenberg C; Rutqvist LE; Skoog L; Sullivan S; Wingren S; Nordenskjöld B J Clin Oncol; 1993 Sep; 11(9):1717-22. PubMed ID: 8355038 [TBL] [Abstract][Full Text] [Related]
65. DNA index and S-phase fraction and their combination as prognostic factors in operable ductal breast carcinoma. Joensuu H; Toikkanen S; Klemi PJ Cancer; 1990 Jul; 66(2):331-40. PubMed ID: 2164437 [TBL] [Abstract][Full Text] [Related]
66. Intratumoral variations in DNA ploidy and s-phase fraction in human breast cancer. Arnerlöv C; Emdin SO; Cajander S; Bengtsson NO; Tavelin B; Roos G Anal Cell Pathol; 2001; 23(1):21-8. PubMed ID: 11790856 [TBL] [Abstract][Full Text] [Related]
67. DNA ploidy and other results of DNA flow cytometry as prognostic factors in operable breast cancer: 10 year results of a randomised study. Gnant MF; Blijham G; Reiner A; Reiner G; Reynders M; Schutte B; van Asche C; Steger G; Jakesz R Eur J Cancer; 1992; 28(2-3):711-6. PubMed ID: 1591097 [TBL] [Abstract][Full Text] [Related]
68. Prognostic significance of flow cytometric DNA analysis in node-negative breast cancer patients. Lewis WE Cancer; 1990 May; 65(10):2315-20. PubMed ID: 2346915 [TBL] [Abstract][Full Text] [Related]
69. Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry. Baldetorp B; Fernö M; Fallenius A; Fallenius-Vecchi G; Idvall I; Olsson H; Sigurdsson H; Akerman M; Killander D Cytometry; 1992; 13(6):577-85. PubMed ID: 1451590 [TBL] [Abstract][Full Text] [Related]
70. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma. Martin G; Halwani F; Shibata H; Meterissian S Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254 [TBL] [Abstract][Full Text] [Related]
71. Flow cytometric analysis of uterine sarcoma: ploidy and S-phase rate as prognostic indicators. Malmström H; Schmidt H; Persson PG; Carstensen J; Nordenskjöld B; Simonsen E Gynecol Oncol; 1992 Feb; 44(2):172-7. PubMed ID: 1544595 [TBL] [Abstract][Full Text] [Related]
72. Evaluation of DNA ploidy and S-phase fraction in fine needle aspirates from breast carcinoma. Panwar S; Handa U; Kaur M; Mohan H; Attri AK Diagn Cytopathol; 2021 Jun; 49(6):761-767. PubMed ID: 33755349 [TBL] [Abstract][Full Text] [Related]
73. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers. Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y Oncol Rep; 2002; 9(4):793-9. PubMed ID: 12066211 [TBL] [Abstract][Full Text] [Related]
74. DNA content flow cytometry as a prognostic factor for node-positive breast cancer. The role of multiparameter ploidy analysis and specimen sonication. Witzig TE; Gonchoroff NJ; Therneau T; Gilbertson DT; Wold LE; Grant C; Grande J; Katzmann JA; Ahmann DL; Ingle JN Cancer; 1991 Oct; 68(8):1781-8. PubMed ID: 1913523 [TBL] [Abstract][Full Text] [Related]
75. Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma. Russo A; Bazan V; Migliavacca M; Zanna I; Tubiolo C; Tumminello FM; Dardanoni G; Cajozzo M; Bazan P; Modica G; Latteri M; Tomasino RM; Colucci G; Gebbia N; Leto G Clin Cancer Res; 2000 Jan; 6(1):178-84. PubMed ID: 10656448 [TBL] [Abstract][Full Text] [Related]
76. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate. Meyer JS; Gersell DJ; Yim S Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140 [TBL] [Abstract][Full Text] [Related]
77. Ki-67, p53, Er-receptors, ploidy and S-phase as prognostic factors in T1 node negative breast cancer. Railo M; Lundin J; Haglund C; von Smitten K; von Boguslawsky K; Nordling S Acta Oncol; 1997; 36(4):369-74. PubMed ID: 9247096 [TBL] [Abstract][Full Text] [Related]
78. Prognostic value of DNA ploidy in 653 Japanese women with node-negative breast cancer. Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S Int J Clin Oncol; 2001 Aug; 6(4):177-82. PubMed ID: 11706555 [TBL] [Abstract][Full Text] [Related]
79. Flow cytometry in primary breast carcinomas: prognostic impact of S-phase fraction according to different analysis patterns. Michels JJ; Marnay J; Plancoulaine B; Chasle J Cytometry B Clin Cytom; 2004 May; 59(1):32-9. PubMed ID: 15108168 [TBL] [Abstract][Full Text] [Related]
80. Prognostic significance of DNA ploidy and S-phase fraction in malignant serous cystadenocarcinoma of the ovary. Bakshi N; Rajwanshi A; Patel F; Ganguly NK Anal Quant Cytol Histol; 1998 Jun; 20(3):215-20. PubMed ID: 9642449 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]